glp 1 retatrutide 8 weeks for weight loss: Study shows 30% body weight loss Switching from tirzepatide to retatrutide:
Description
Purity & Testing Purity verified at 99.2% by HPLC
Results Descriptive analysis In total, 141,323 GLP-1RA-associated adverse events and 36,084 reported cases of hypoglycemia were included in the FAERS database from January 2004 to September 2020
The triple receptor mechanism of retatrutide, particularly the glucagon receptor component, contributes to higher GI side effect rates overall
doi: 10.1253/circj.CJ-16-0152 [DOI] [PubMed] [Google Scholar] 54.Ussher JR, Campbell JE, Mulvihill EE, et al
What are the safety considerations for long-term GLP-1 use
37 However, pegbelfermin administered weekly for 48 weeks did not achieve a one-stage or greater improvement in the NASH Clinical Research Network fibrosis score without worsening NASH, as assessed via biopsy in the phase 2B FALCON 2 study (NCT03486912)
